These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 24519110)
21. Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy--a pilot study at 1.5 T. Kirsch EC; Kaim AH; De Oliveira MG; von Arx G Neuroradiology; 2010 Feb; 52(2):91-7. PubMed ID: 19756565 [TBL] [Abstract][Full Text] [Related]
22. Quantitative T1 mapping MRI for the assessment of extraocular muscle fibrosis in thyroid-associated ophthalmopathy. Ma R; Geng Y; Gan L; Peng Z; Cheng J; Guo J; Qian J Endocrine; 2022 Feb; 75(2):456-464. PubMed ID: 34549377 [TBL] [Abstract][Full Text] [Related]
23. Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance. Chen L; Hu H; Chen HH; Chen W; Wu Q; Wu FY; Xu XQ Br J Radiol; 2021 Feb; 94(1118):20200884. PubMed ID: 33353397 [TBL] [Abstract][Full Text] [Related]
24. Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy. Higashiyama T; Nishida Y; Morino K; Ugi S; Nishio Y; Maegawa H; Ohji M Jpn J Ophthalmol; 2015 Mar; 59(2):124-30. PubMed ID: 25448468 [TBL] [Abstract][Full Text] [Related]
26. Thyroid-Associated Ophthalmopathy: Preliminary Study Using T2 Mapping to Characterize Intraorbital Optic Nerve Changes Before Dysthyroid Optic Neuropathy. Hu H; Chen HH; Chen W; Wu Q; Chen L; Zhu H; Shi HB; Xu XQ; Wu FY Endocr Pract; 2021 Mar; 27(3):191-197. PubMed ID: 33630733 [TBL] [Abstract][Full Text] [Related]
27. Quantitative assessment of extraocular muscles in Graves' ophthalmopathy using T1 mapping. Zhu H; Zou M; Wu D; Li B; Su Y; Li Y; Hong S; Yang Z Eur Radiol; 2023 Dec; 33(12):9074-9083. PubMed ID: 37466707 [TBL] [Abstract][Full Text] [Related]
28. Turbo Gradient and Spin-Echo BLADE-DWI for Extraocular Muscles in Thyroid-Associated Ophthalmopathy. Fu Q; Liu D; Ma H; Zhou K; Yin T; Zheng C; Lei Z J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615144 [No Abstract] [Full Text] [Related]
29. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy]. Rodríguez-González N; Pérez-Rico C; López-Para Giménez R; Arévalo-Serrano J; Del Amo García B; Calzada Domingo L; Flores Ruiz L; Blanco R Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641 [TBL] [Abstract][Full Text] [Related]
30. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy. Yokoyama N; Nagataki S; Uetani M; Ashizawa K; Eguchi K Thyroid; 2002 Mar; 12(3):223-7. PubMed ID: 11952043 [TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy. Byun JS; Moon NJ; Lee JK Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):413-420. PubMed ID: 27838736 [TBL] [Abstract][Full Text] [Related]
32. T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study. Das T; Roos JCP; Patterson AJ; Graves MJ; Murthy R Eye (Lond); 2019 Feb; 33(2):235-243. PubMed ID: 30538310 [TBL] [Abstract][Full Text] [Related]
33. [Extraocular muscle involvement in patients with thyroid-associated orbitopathy]. Karhanová M; Kovář R; Fryšák Z; Zapletalová J; Marešová K; Sín M; Heřman M Cesk Slov Oftalmol; 2014 Apr; 70(2):66-71. PubMed ID: 25030316 [TBL] [Abstract][Full Text] [Related]
34. [Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles]. Yang M; Du BX; Wang YJ; He WM Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):510-515. PubMed ID: 34018373 [TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis. Kvetny J; Puhakka KB; Røhl L Acta Ophthalmol Scand; 2006 Jun; 84(3):419-23. PubMed ID: 16704711 [TBL] [Abstract][Full Text] [Related]
36. Radiological Staging of Thyroid-Associated Ophthalmopathy: Comparison of T1 Mapping with Conventional MRI. Chen L; Chen W; Chen HH; Wu Q; Xu XQ; Hu H; Wu FY Int J Endocrinol; 2020; 2020():2575710. PubMed ID: 33144856 [TBL] [Abstract][Full Text] [Related]
37. Correlation Analysis between Intraocular Pressure and Extraocular Muscles Based on Orbital Magnetic Resonance T2 Mapping in Thyroid-Associated Ophthalmopathy Patients. Luo B; Wang W; Li X; Zhang H; Zhang Y; Hu W J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887744 [TBL] [Abstract][Full Text] [Related]
38. Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents. Barendregt AM; van Gulik EC; Lavini C; Nusman CM; van den Berg JM; Schonenberg-Meinema D; Dolman KM; Kuijpers TW; Hemke R; Maas M Eur Radiol; 2017 Nov; 27(11):4889-4899. PubMed ID: 28608162 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of activity of Graves' orbitopathy with multiparameter orbital magnetic resonance imaging (MRI). Cheng J; Zhang X; Lian J; Piao Z; Zhou L; Gou X; Chen C; Chen L; Jiang K; Cheng J; Ji L; Hong N Quant Imaging Med Surg; 2023 May; 13(5):3040-3049. PubMed ID: 37179934 [TBL] [Abstract][Full Text] [Related]